advertisement

WGA Rescources

Pharmaceutics 8

Showing records 1 to 8 | Display all abstracts in Pharmaceutics

98953 Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release
Brugnera M
Pharmaceutics 2022; 14:
98954 New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
Alviset G; Corvis Y
Pharmaceutics 2022; 14:
98953 Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release
Vicario-de-la-Torre M; Andrés-Guerrero V
Pharmaceutics 2022; 14:
98954 New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
Hammad K
Pharmaceutics 2022; 14:
98953 Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release
Bravo-Osuna I
Pharmaceutics 2022; 14:
98954 New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
Lemut J; Maury M
Pharmaceutics 2022; 14:
98953 Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release
Molina-Martínez IT; Herrero-Vanrell R
Pharmaceutics 2022; 14:
98954 New Preservative-Free Formulation for the Enhanced Ocular Bioavailability of Prostaglandin Analogues in Glaucoma
Mignet N; Boudy V
Pharmaceutics 2022; 14:

Issue 22-4

Change Issue


advertisement

WGA Rescources